Skip to content

VolitionRx Limited: 10-Q filed 2026-08-13

What VolitionRx Limited reported in its quarterly report filed 2026-08-13 (fiscal Q2 2026): 44 published measures, 117 facts as tagged in accession 0001477932-26-004995.

This filing

Form
10-Q (quarterly report)
Filed
2026-08-13
Fiscal period
fiscal Q2 2026
Accession
0001477932-26-004995 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VolitionRx Limited filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2026-06-308,300,986USD
At 2025-12-316,901,227USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2026-06-3041,840,346USD
At 2025-12-3142,494,038USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2026-06-30-32,164,943USD
At 2025-12-31-34,246,393USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2026-06-302,800,000USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-7,326,047USD91
2026-01-01 to 2026-06-30-13,990,821USD181
2025-04-01 to 2025-06-30-6,284,078USD91
2025-01-01 to 2025-06-30-11,707,837USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2026-01-01 to 2026-06-30-10,439,781USD181
2025-01-01 to 2025-06-30-10,560,707USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2026-01-01 to 2026-06-3011,002USD181
2025-01-01 to 2025-06-3078,591USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2026-04-01 to 2026-06-30398,657USD91
2026-01-01 to 2026-06-301,383,733USD181
2025-04-01 to 2025-06-30406,688USD91
2025-01-01 to 2025-06-30653,073USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2026-01-01 to 2026-06-3012,595,212USD181
2025-01-01 to 2025-06-309,337,104USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2026-01-01 to 2026-06-30-11,002USD181
2025-01-01 to 2025-06-30-78,591USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2026-06-30-267,352,291USD
At 2025-12-31-252,901,370USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2026-04-01 to 2026-06-309,154,815shares91
2026-01-01 to 2026-06-308,018,292shares181
2025-04-01 to 2025-06-305,132,705shares91
2025-01-01 to 2025-06-304,980,599shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-0.85USD/shares91
2026-01-01 to 2026-06-30-1.8USD/shares181
2025-04-01 to 2025-06-30-1.22USD/shares91
2025-01-01 to 2025-06-30-2.35USD/shares181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2026-06-303,564,114USD
At 2025-12-314,027,849USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2026-01-01 to 2026-06-30462,985USD181
2025-01-01 to 2025-06-301,263,419USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-4,155,983USD91
2026-01-01 to 2026-06-30-9,527,671USD181
2025-04-01 to 2025-06-30-6,297,807USD91
2025-01-01 to 2025-06-30-11,819,197USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2026-06-304,092,944USD
At 2025-12-312,060,925USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2026-06-3013,492,636USD
At 2025-12-3112,230,753USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2026-06-303,564,762USD
At 2025-12-312,918,768USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2026-06-30305,133USD
At 2025-12-31316,704USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2026-06-30277,355USD
At 2025-12-31317,808USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2026-04-01 to 2026-06-304,554,640USD91
2026-01-01 to 2026-06-3010,911,404USD181
2025-04-01 to 2025-06-306,704,495USD91
2025-01-01 to 2025-06-3012,472,270USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2026-04-01 to 2026-06-301,800,656USD91
2026-01-01 to 2026-06-304,652,907USD181
2025-04-01 to 2025-06-302,720,207USD91
2025-01-01 to 2025-06-305,327,321USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2026-06-3012,044,339shares
At 2025-12-316,288,988shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2026-06-302,790,994USD
At 2025-12-311,117,028USD
At 2025-06-302,255,996USD
At 2024-12-313,264,429USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2026-06-30235,263,755USD
At 2025-12-31218,943,759USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2026-06-30-88,451USD
At 2025-12-31-295,071USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2026-06-30-33,539,360USD
At 2026-03-31-33,359,929USD
At 2025-12-31-35,592,811USD
At 2025-06-30-33,098,322USD
At 2025-03-31-29,026,675USD
At 2024-12-31-26,107,736USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2026-06-30338,795USD
At 2025-12-31495,749USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2026-06-307,051,835USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2026-06-3010,177,870USD
At 2025-12-3110,421,397USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2026-06-306,613,756USD
At 2025-12-316,393,548USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2026-06-302,670,128USD
At 2025-12-314,211,828USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-7,315,263USD91
2026-01-01 to 2026-06-30-14,018,820USD181
2026-01-01 to 2026-03-31-6,703,557USD90
2025-04-01 to 2025-06-30-6,314,070USD91
2025-01-01 to 2025-06-30-11,790,697USD181
2025-01-01 to 2025-03-31-5,476,627USD90

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-7,242,950USD91
2026-01-01 to 2026-06-30-13,812,200USD181
2025-04-01 to 2025-06-30-6,890,066USD91
2025-01-01 to 2025-06-30-12,620,622USD181

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2026-01-01 to 2026-06-3014,000,000USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2026-04-01 to 2026-06-302,205,471USD91
2026-01-01 to 2026-06-304,858,283USD181
2025-04-01 to 2025-06-302,940,754USD91
2025-01-01 to 2025-06-305,184,116USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2026-01-01 to 2026-06-30383,065USD181
2025-01-01 to 2025-06-30492,925USD181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2026-01-01 to 2026-06-3012,319USD181
2025-01-01 to 2025-06-3012,028USD181

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2026-04-01 to 2026-06-30740,388USD91
2026-01-01 to 2026-06-30866,230USD181
2025-04-01 to 2025-06-30123,356USD91
2025-01-01 to 2025-06-30220,025USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-3,159,280USD91
2026-01-01 to 2026-06-30-4,491,149USD181
2025-04-01 to 2025-06-30-16,263USD91
2025-01-01 to 2025-06-3028,500USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2026-01-01 to 2026-06-30242,897USD181
2025-01-01 to 2025-06-30220,025USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2026-01-01 to 2026-06-3010,608,848USD181
2025-01-01 to 2025-06-302,447,214USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2026-01-01 to 2026-06-30-40,453USD181
2025-01-01 to 2025-06-3079,023USD181

Inspect the source

Entity
VolitionRx Limited / CIK 0000093314
Captured
2026-09-19T14:52:44.598Z
SEC response SHA-256
254eb18dbeb68035bca746c45eba900407d99a5725acd9eefccf66cdb02b0404

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000093314.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))